4 その他
(1) 契約手続において使用する言語及び通貨
日本語及び日本国通貨。
(2) 入札保証金及び契約保証金 免除。
(3) 入札者に要求される事項 この一般競争に
参加を希望する者は、封印した入札書に本公
告に示した物品を納入できることを証明する
書類を添付して入札書の受領期限までに提出
しなければならない。入札者は、開札日の前
日までの間において、分任契約担当役から当
該書類に関し説明を求められた場合は、それ
に応じなければならない。
(4) 入札の無効 本公告に示した競争参加資格
のない者の提出した入札書、入札者に求めら
れる義務を履行しなかった者の提出した入札
書、その他入札説明書による。
(5) 契約書作成の要否 要。
(6) 落札者の決定方法 本公告に示した物品又
はこれと同等のものを納入できると分任契約
担当役が判断した入札者であって、国立大学
法人筑波大学財務規則施行規程第53条の規定
に基づいて作成された予定価格の制限の範囲
内で最低価格をもって有効な入札を行った入
札者を落札者とする。
(7) 手続における交渉の有無 無。
(8) その他 詳細は、入札説明書による。なお、
入札説明書等で当該調達に関する環境上の条
件を定めた調達であると示されている場合
は、十分理解した上で応札すること。
5 Summary
(1) Official in charge of disbursement of the
procuring entity: HIRAMASTU Yuji, The
Obligating Officer Director, University of
Tsukuba Hospital
(2) Classification of the products to be procured : 4
(3) Nature and quantity of the products to be purchased :
A Pembrolizumab (Genetical Recombination) 100mg/4mL 1vial/case about 3560cases
B Nivolumab (Genetical Recombination)
240mg/24mL 1vial/case about 1620-cases
C Vutrisiran Sodium 25mg/0.5mL 1syringe/case about 20cases
D Daratumumab (Genetical Recombination)・Vorhyaluronidase Alfa (Genetical Recombination) 15mL 1vial/case about 580cases
E Efgartigimod Alfa (Genetical Recombination) 400mg/20mL 1vial/case about 650cases
F Durvalumab (Genetical Recombination) 500mg/10mL 1vial/case about 720cases
G Elranatamab (Genetical Recombination) 76mg/1.9mL 1vial/case about 190-cases
H Teprotumumab (Genetical Recombination) 500mg 1vial/case about 190-cases
I Epcoritamab (Genetical Recombination) 48mg/0.8mL 1vial/case about 60-cases
J Ipilimumab (Genetical Recombination)
50mg/10mL 1vial/case about 250cases
K Amivantamab (Genetical Recombination) 350mg/7mL 1vial/case about 390cases
L Risankizumab (Genetical Recombination) 150mg / 1mL 1syringe / case about 330cases
M Paclitaxel 100mg 1vial/case about 3230cases
N Canakinumab (Genetical Recombination) 150mg/1mL 1vial/case about 70cases
O Risankizumab (Genetical Recombination) 360mg/2.4mL 1kit/case about 200cases
P Trastuzumab Deruxtecan (Genetical Recombination) 100mg 1vial/case about 540cases
Q Lenalidomide Hydrate 5mg 40capsules/case about 320cases
R Atezolizumab (Genetical Recombination) 1200mg/20mL 1vial/case about 190cases
S Blinatumomab (Genetical Recombination) 35μg 1vial/case about 270cases
T Afibercept (Genetical Recombination)
40mg 1syringe/case about 1040cases
U Efgartigimod Alfa (Genetical Recombination) ・ Vorhyaluronidase Alfa (Genetical Recombination) 5mg 1syringe/case about 150cases
V Avelumab (Genetical Recombination)
200mg 1vial/case about 730cases
W Avalglucosidase Alfa (Genetical Recombination) 100mg 1vial/case about 520cases
X Sotatercept (Genetical Recombination)
45mg 1vial/case about 80cases
Y Aflibercept (Genetical Recombination)
8mg 1syringe/case about 510cases
Z Datopotamab Deruxtecan (Genetical Recombination) 100mg 1vial/case about 170cases
AA Sacituzumab Govitecan (Genetical Recombination) 200mg 1vial/case about 330cases
AB Nirsevimab (Genetical Recombination) 50mg / 0.5mL 1syringe / case about 160cases
AC Polyethylene Glycol Treated Human Normal Immunoglobulin 10g / 100mL 1vial/case about 790cases
AD Faricimab (Genetical Recombination) 6mg/0.05mL 1syringe/case about 530cases
AE Letermovir 240mg 14tablets/case about 350cases
AF Romiplostim (Genetical Recombination) 250μg 1vial/case about 1440-cases
AG Irinotecan Hydrochloride Hydrate
43mg/10mL 1vial/case about 530cases
AH pH4-Treated Normal Human Immunoglobulin 10g/100mL 1vial/case about 520cases
AI Enfortumab Vedotin (Genetical Recombination) 30mg 1vial/case about 850cases
AJ Brentuximab Vedotin (Genetical Recombination) 50mg 1vial/case about 180cases
AK Infliximab (Genetical Recombination) 100mg 1vial/case about 1270cases
AL Denosumab (Genetical Recombination) 120mg / 1mL 1syringe / case about 1210cases
AM Evinacumab (Genetical Recombination) 345mg/2.3mL 1vial/case about 40cases
AN Ramucirumab (Genetical Recombination) 500mg / 50mL 1vial / case about 160cases
AO Tarlatamab (Genetical Recombination) 10mg 1vial/case about 40cases
AP Trastuzumab Emtansine (Genetical Recombination) 100mg 1vial/case about 170cases
AQ Pegfilgrastim (Genetical Recombination) 3.6mg / 0.36mL 1kit / case about 600cases
AR pH4-Treated Normal Human Immunoglobulin 20g/200mL 1vial/case about 270cases
AS Tremelimuab (Genetical Recombination) 300mg / 15mL 1vial / case about 10cases
AT Ustekinumab (Genetical Recombination) 45mg / 0.5mL 1syringe/case about 280cases
AU Abatacept (Genetical Recombination) 250mg 1vial/case about 860cases
AV Maribavir 200mg 28tablets / case about 30cases
AW Inebilizumab (Genetical Recombination) 100mg/10mL 3vials/case about 5cases
AX Cetuximab (Genetical Recombination) 100mg/20mL 1vial/case about 1750cases
AY Guselkumab (Genetical Recombination) 100mg / 1mL 1syringe / case about 130cases
AZ Fosnetupitant Chloride Hydrochloride 235mg 5vials/case about 690cases
BA Zolbetuximab (Genetical Recombination) 100mg 1vial/case about 760-cases
BB Obinutuzumab (Genetical Recombination) 1000mg / 40mL 1vial / case about 120cases
BC Leuprorelin Acetate 11.25mg 1syringe/case about 900cases
BD Nirsevimab (Genetical Recombination) 100mg / 1mL 1syringe / case about 50cases